Loading clinical trials...
Loading clinical trials...
An Open-Label, Single-Dose Study to Evaluate the Pharmacokinetics of MCI-186 in Subjects With Mild or Moderate Renal Impairment Compared to Subjects With Normal Renal Function
Conditions
Interventions
MCI-186
Locations
1
Japan
Investigational site
Tokyo, Japan
Start Date
October 27, 2016
Primary Completion Date
April 16, 2018
Completion Date
April 20, 2018
Last Updated
January 8, 2026
NCT00104325
NCT07388667
NCT03878121
NCT05447416
NCT01399385
NCT07090785
Lead Sponsor
Tanabe Pharma Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions